Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer

Clinical trial NCT00088933 · TERMINATED

Trial details

NCT number: NCT00088933
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer Recurrent Colon Cancer Recurrent Non-small Cell Lung Cancer Recurrent Rectal Cancer Recurrent Small Cell Lung Cancer Stage IV Colon Cancer Stage IV Non-small Cell Lung Cancer Stage IV Rectal Cancer

Start date: 2004-06-01
Primary completion: 2007-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.